Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet and Antioxidant Agents for Drusen Progression in Dry AMD
NCT06165068Phase 3Recruiting
- Sponsor
- Navamindradhiraj University
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in age-related macular degeneration (AMD), sponsored by Navamindradhiraj University. Started Dec 2023; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT06165068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06165068.